Immutep IMMP
NASDAQ IMMP
$3.26 +0.03 (+0.77%)
As of: Oct 21, 2026 · 3:25 PM EDT

Immutep (IMMP) Notes Payables (2014 - 2015)

Updated

Immutep (IMMP) recorded Notes Payables of $570,627 in the quarter ended Dec 31, 2014.

Analysis

Immutep (IMMP) Notes Payables (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Immutep 23.69 Mn -187.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1.51 Mn
Dec 31, 2014 545,936.66
API Access

Immutep Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IMMP&period=max&api_key=YOUR_API_KEY